Back to UBS Group AG UBS Group AG

KPRXKPRX
Showing 8 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in KIORA PHARMACEUTICALS INC

UBS Group AG holds 1,961 shares of KPRX (KIORA PHARMACEUTICALS INC), worth $5,157 as of 2026-Q2. The position was increased (+50.7% shares).

Current Value

$5,157

Current Shares

1,961

Total Value Change

+$3,862

Total Shares Change

+1,607

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1,961
+50.7%
$5,1570.0%$2.63
14
2026-Q1
Increased
1,301
+42.6%
$2,5110.0%$2.02
11
2025-Q4
Decreased
912
-33.1%
$1,7970.0%$1.94
0
2025-Q3
Decreased
1,364
-92.3%
$3,7920.0%$2.63
0
2025-Q2
Increased
17,644
+8821x
$50,8150.0%$2.90
23
2025-Q1
Unchanged
2
0.0%
$60.0%$3.08
0
2024-Q4
Decreased
2
-99.4%
$70.0%$3.30
0
2024-Q3
Decreased
354
-95.8%
$1,2950.0%$3.43
0

Other major holders of KPRX: Alyeska Investment Group, L.P., CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used